be transported to the most appropriate medical facility capable of managing their problems.
References
1 1 Cain E, Ackroyd‐Stolarz S, Alexiadia P, Murray D. Prehospital hypoglycemia: the safety of not transporting treated patients. Prehosp Emerg Care. 2003; 7:458–65.
2 2 Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. Atlanta, GA: CDC, 2011.
3 3 Center for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States. Atlanta, GA: CDC, 2020.
4 4 Menchine MD, Wiechmann W, Peters AL, Arora S. Trends in diabetes‐related visits to US EDs from 1997 to 2007. Am J Emerg Med. 2012; 30:754–8.
5 5 Gao F, Luo H, Jones K, Nicholson W, Bell RA. Gestational diabetes and health behaviors among women: national health and nutrition examination survey, 2007‐2014. Prev Chronic Dis. 2018; 15:E131.
6 6 Benoit SR, Kahn HS, Geller AI, et al. Diabetes‐related emergency medical service activations in 23 States, United States 2015. Prehosp Emerg Care. 2018; 22:705–712.
7 7 Clawson J, Scott G, Lloyd W, et al. Outcome accuracy of the emergency medical dispatcher’s initial selection of the diabetic problems protocol. Prehosp Disaster Med. 2014; 29:37–42.
8 8 Hoffman JR, Schriger DL, Votey SR, Luo JS. The empiric use of hypertonic dextrose in patients with altered mental status: a reappraisal. Ann Emerg Med. 1992; 21:20–24.
9 9 Browning RG, Olson DW, Stueven HA, Mateer JR. 50% dextrose: antidote or toxin. Ann Emerg Med. 1990; 19:113–17.
10 10 Jones JL, Ray VG, Gough JE, Garrison HG, Whitley TW. Determination of prehospital blood glucose: a prospective, controlled study. J Emerg Med. 1992; 10:679–82.
11 11 Lavery RF, Allegra JR, Cody RP, Zacharias D, Schreck DM. A prospective evaluation of glucose reagent test strips in the prehospital setting. Am J Emerg Med. 1991; 9:304–308.
12 12 Herr RD. Effect of time and storage conditions of Chemstrip bG on estimating blood glucose aboard ambulances. J Int Fed Clin Chem. 1992; 4:71–75.
13 13 Lee AK, Warren B, Lee CJ, et al. The association of severe hypoglycemia with incident cardiovascular events and mortality in adults with type 2 diabetes. Diabetes Care. 2018; 41:104–111.
14 14 Hern HG, Kiefer M, Louie D, Barger J, Alter HJ. D10 in the treatment of prehospital hypoglycemia: A 24 month observational cohort study. Prehosp Emerg Care. 2017; 21:63–67.
15 15 Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycemia in 411 type 1 diabetic patients. Diabetes Med. 1991; 8: 217–22.
16 16 Pedersen‐Bjergaard U, Pramming S, Heller SP, et al. Severe hypoglycemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev. 2004; 20:479–86.
17 17 MacLeod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycemia in insulin‐treated diabetic patients. Diabetes Med. 1993; 10:238–45.
18 18 Ter Braak EWMT, Appleman AMMF, van de Laak MF, et al. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care. 2000; 23:1467–71.
19 19 Adler PM. Serum glucose changes after administration of 50% dextrose solutions. Am J Emerg Med. 1986; 4:504–506.
20 20 DeLorenzo RA, Vista JP. Another hazard of hypertonic dextrose. Am J Emerg Med. 1994; 12:262–3.
21 21 Lawson SL, Brady W, Mahmoud A. Identification of highly concentrated dextrose solution (50% dextrose) extravasation and treatment–a clinical report. Am J Emerg Med. 2013; 31:886.e3–5.
22 22 Sanello A, Gausche‐Hill M, Mulkerin W, et al. Altered mental status: current evidence‐based recommendations for prehospital care. West J Emerg Med. 2018; 19:527–41.
23 23 Kiefer MV, Hern GH, Alter HJ, Barger JB. Dextrose 10% in the treatment of out‐of‐hospital hypoglycemia. Prehosp Dis Med. 2014; 29:190–4.
24 24 Moore C, Woollard M. Dextrose 10% or 50% in the treatment of hypoglycaemia out of hospital? A randomized controlled trial. Emerg Med J. 2005; 22:512–15.
25 25 Woodburn EV, Rostykus PS. Prehospital management of hypoglycemic emergencies: evidence‐based review for collegiate‐based emergency medical services. J Coll Emerg Med Serv. 2019; 2:9–15.
26 26 Vukmir RB, Paris PM, Yealy DM. Glucagon: prehospital therapy for hypoglycemia. Ann Emerg Med. 1991; 20:375–9.
27 27 Carstens S, Sprehn M. Prehospital treatment of severe hypoglycemia: a comparison of intramuscular glucagon and intravenous glucose. Prehosp Dis Med 1998; 13:114–25.
28 28 Vermeulen MJ, Klompas M, Ray JG, Mazza C, Morrison LJ. Subcutaneous glucagon may be better than oral glucose for prehospital treatment of symptomatic hypoglycemia. Diabetes Care. 2003; 26:2472–3.
29 29 Hvidberg A, Djurup R, Hilsted J. Glucose recovery after intranasal glucagon during hypoglycemia in man. Eur J Clin Pharmacol. 1994; 46:15–17.
30 30 Sibley T, Jacobsen R, Salomone J. Successful administration of intranasal glucagon in the out‐of‐hospital environment. Prehosp Emerg Care. 2013; 17:98–102.
31 31 Pontiroli AE, Tagliabue E. Therapeutic use of intranasal glucagon: resolution of hypoglycemia. Int J Mol Sci. 2019; 20:3646.
32 32 Deeb LC, Dulude H, Guzman CB, et al. A phase 3 multicenter, open‐label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setting. Pediatr Diabetes. 2018; 19:1007–13.
33 33 Yale JF, Dulude H, Egeth M, et al. Faster use and fewer failures with needle‐free nasal glucagon versus injectable glucagon in severe hypoglycemia rescue: a simulation study. Diabetes Technol Ther. 2017; 19:423–32.
34 34 Rickels MR, Ruedy KJ, Foster NC, et al. Intranasal glucagon for treatment of insulin‐induced hypoglycemia in adults with type 1 diabetes: a randomized crossover. Diabet Care. 2016; 39:264–70.
35 35 Lin SF, Lin JD, Huang YY. Diabetic ketoacidosis: comparisons of patient characteristics, clinical presentations and outcomes today and 20 years ago. Chang Gung Med J. 2005; 28:24–30.
36 36 Gallo de Moraes A, Surani S. Effects of diabetic ketoacidosis in the respiratory system. World J Diabetes. 2019; 10:16–22.
37 37 Adeyinka A, Kondamudi NP. Hyperosmolar Hyperglycemic Nonketotic Coma. (HHNC, Hyperosmolar Hyperglycemic Nonketotic Syndrome). Treasure Island, FL: StatPearls Publishing; 2020.
38 38 Remick K, Redgate C, Ostermayer D, Kaji AH, Gausche‐Hill M. Prehospital glucose testing for children with seizures: a proposed change in management. Prehosp Emerg Care. 2017; 21:216–21.
39 39 Rosenn BM, Miodovnik M, Holcberg C, et al. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin dependent diabetes mellitus. Obstet Gynecol. 1995; 85:417–22.
40 40 Gabbe SG, Carlenter LB, Garrison EA. New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy. Clin Obstet Gynecol. 2007; 50:1014–24.
41 41 Efrimescu CI, Yagoub E, Doyle R. Intentional insulin overdose associated with minimal hypoglycemic symptoms in a non‐diabetic patient. Maedica (Buchar) 2013; 8:365–9.
42 42 Shibutani Y, Ogawa C. Suicidal insulin overdose in a type 1 diabetic patient: relation of serum insulin concentrations to the duration of hypoglycemia. J Diabet Complications. 2000; 14:60–62.
43 43 Roberge RJ, Martin TG, Delbridge TR. Intentional massive insulin overdose: recognition and management. Ann Emerg Med. 1993; 22:228–34.
44 44 Fuller ET, Miller MA, Kaylor DW, Janke C. Lantus over‐dose: case presentation and management options. J Emerg Med. 2009: 36:26–9.
45 45